CAN PROLACTIN BE A MARKER FOR DEVELOPMENT AND PROGRESSION OF PCOS?
- 1 October 2021
- journal article
- Published by World Wide Journals
Abstract
Background: Polycystic ovarian syndrome has been one of a major public health problem. It causes multifactorial in etiology such as menstrual dysfunction, hyperandrogenism, hirsutism, insulin resistance, dyslipidemia and obesity which increased risk of diabetes mellitus and cardiovascular disease. Prolactin has been reported as a potent lipogenic and diabetogenic factor, that affecting energy balance and fuel metabolism. The present study was designed to assess serum prolactin and insulin resistance in PCOS women and to compare them with healthy women as controls. Material And Methods: A comparative study including 50 women newly diagnosed as PCOS and 50 healthy women as controls was conducted. The age group for the study was 18-35 years. Fasting blood samples were drawn to assess serum prolactin, serum insulin and fasting blood sugar. Insulin resistance was calculated by homeostasis model assessment. Results: A signicant increase in fasting serum insulin (p<0.001) and HOMA – IR (p<0.001) were found in patients with PCOS in comparison with controls. Prolactin and FPG were found elevated in the PCOS women and were statistically signicant. Conclusions: The current study provides further evidence that signicantly higher fasting insulin and HOMA in PCOS group indicates presence of IR. IR in PCOS group may have a potential role in the prediction of dysglycemic disease in women with PCOS. This study found signicant correlation between serum prolactin and serum insulinKeywords
This publication has 15 references indexed in Scilit:
- Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening methodHuman Reproduction, 2013
- Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?BMC Endocrine Disorders, 2013
- Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary SyndromeInternational Journal of Endocrinology, 2012
- Differential and Complementary Effects of Glucose and Prolactin on Islet DNA Synthesis and Gene ExpressionEndocrinology, 2011
- The Phenotypes of Polycystic Ovary Syndrome Defined by the 1990 Diagnostic Criteria Are Associated with Higher Serum Vaspin Levels than the Phenotypes Introduced by the 2003 CriteriaObesity Facts, 2011
- Insulin resistance and polycystic ovary syndromeNutrition, Metabolism and Cardiovascular Diseases, 2008
- The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndromeActa Endocrinologica, 2006
- Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary SyndromeObstetrical & Gynecological Survey, 1999
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.BMJ, 1986
- The increasing concern with infertility. Why now?JAMA, 1983